Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Tedelparin

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 10Fragmin

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Fragmin

    Dalteparin

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer Inc.

    Dalteparin

    Main Therapeutic Indication : Hematology

    Currency : USD

    2019 Revenue in Millions : 253

    2018 Revenue in Millions : 293

    Growth (%) : -14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Fragmin

    Dalteparin

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer Inc.

    Dalteparin

    Main Therapeutic Indication : Hematology

    Currency : USD

    2020 Revenue in Millions : 252

    2019 Revenue in Millions : 253

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Fragmin

    Dalteparin

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer Inc.

    Dalteparin

    Main Therapeutic Indication : Hematology

    Currency : USD

    2021 Revenue in Millions : 305

    2020 Revenue in Millions : 252

    Growth (%) : 21

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Fragmin

    Dalteparin

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer Inc.

    Dalteparin

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2022 Revenue in Millions : 269

    2021 Revenue in Millions : 305

    Growth (%) : -12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Fragmin

    Dalteparin

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer Inc.

    Dalteparin

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2023 Revenue in Millions : 238

    2022 Revenue in Millions : 269

    Growth (%) : -12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Fragmin

    Dalteparin

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer Inc.

    Dalteparin

    Main Therapeutic Indication : Anticoagulants

    Currency : USD

    2014 Revenue in Millions : 1.40%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Fragmin

    Dalteparin

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer Inc.

    Dalteparin

    Main Therapeutic Indication : Anticoagulants

    Currency : USD

    2015 Revenue in Millions : 364

    2014 Revenue in Millions : 335

    Growth (%) : -8%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Fragmin

    Dalteparin

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer

    Dalteparin

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2016 Revenue in Millions : 318

    2015 Revenue in Millions : 335

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Fragmin

    Dalteparin

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer Inc.

    Dalteparin

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2017 Revenue in Millions : 306

    2016 Revenue in Millions : 318

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Fragmin

    Dalteparin

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Fragmin

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer

    Dalteparin

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2018 Revenue in Millions : 293

    2017 Revenue in Millions : 306

    Growth (%) : -4%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF